These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22165380)

  • 1. With the advent of sugammadex, a succinylcholine-free anaesthetic in electroconvulsive therapy may be the future standard.
    Chow TK
    Anaesth Intensive Care; 2011 Nov; 39(6):1154-5. PubMed ID: 22165380
    [No Abstract]   [Full Text] [Related]  

  • 2. Electroconvulsive therapy using rocuronium and sugammadex in patient with neuroleptic malignant syndrome.
    Saeki N; Kwon R; Migita T; Fukuda H; Hamada H; Kawamoto M
    Anaesth Intensive Care; 2011 Jul; 39(4):762-3. PubMed ID: 21823397
    [No Abstract]   [Full Text] [Related]  

  • 3. Rocuronium-sugammadex for electroconvulsive therapy management in neuroleptic malignant syndrome: A case report.
    Casas Reza P; Gestal Vázquez M; Outeiro Rosato Á; López Álvarez S; Diéguez García P
    Rev Esp Anestesiol Reanim; 2017 Feb; 64(2):105-107. PubMed ID: 27424873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rocuronium reversed by sugammadex for electroconvulsive therapy in a patient with prolonged duration of action of succinylcholine.
    Visser WA; Ermens AA; De Boer HD; Van Os E
    Anaesth Intensive Care; 2011 Nov; 39(6):1153-4. PubMed ID: 22165379
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anesthetic management for electroconvulsive therapy using rocuronium bromide and sugammadex sodium in a patient with suspected malignant syndrome].
    Maeda T; Enomoto T; Kamiyama Y; Inada E
    Masui; 2011 Dec; 60(12):1384-6. PubMed ID: 22256579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anesthesia and electroconvulsive therapy: when succinylcholine is contraindicated.
    González A; Benavides J; Lema G
    J ECT; 2013 Mar; 29(1):75-6. PubMed ID: 23422522
    [No Abstract]   [Full Text] [Related]  

  • 7. Near miss with succinylcholine for electroconvulsive therapy: a case report.
    Koster TD; Kooistra WE; Tuinman AG
    Eur J Anaesthesiol; 2014 Aug; 31(8):441-3. PubMed ID: 24849504
    [No Abstract]   [Full Text] [Related]  

  • 8. Rocuronium and sugammadex as a novel management strategy in a patient with plasmacholinesterase deficiency presenting for electroconvulsive therapy.
    Eissa S; Lim KS
    Anaesth Intensive Care; 2011 Jul; 39(4):764-5. PubMed ID: 21823399
    [No Abstract]   [Full Text] [Related]  

  • 9. Rocuronium-sugammadex use in electroconvulsive therapy of patients with pseudocholinesterase enzyme deficiency.
    Yuksel E; Sergin D; Tanatti B; Alper I
    J Clin Anesth; 2013 Dec; 25(8):680-1. PubMed ID: 24095888
    [No Abstract]   [Full Text] [Related]  

  • 10. Rocuronium-sugammadex as an alternative to succinylcholine in electroconvulsive therapy.
    Yalcin S; Aydogan H; Serdaroglu H
    J Anesth; 2011 Aug; 25(4):631; author reply 632. PubMed ID: 21607768
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of rocuronium and sugammadex in a patient with a history of suxamethonium allergy.
    Messer B; Wilkes J
    Anaesthesia; 2011 Sep; 66(9):844. PubMed ID: 21831084
    [No Abstract]   [Full Text] [Related]  

  • 12. Does rocuronium-sugammadex reduce myalgia and headache after electroconvulsive therapy in patients with major depression?
    Saricicek V; Sahin L; Bulbul F; Ucar S; Sahin M
    J ECT; 2014 Mar; 30(1):30-4. PubMed ID: 23812022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Titration of electroconvulsive therapy: the use of rocuronium and sugammadex with adjunctive laryngeal mask.
    Chow TK
    Br J Anaesth; 2012 May; 108(5):882-3. PubMed ID: 22499756
    [No Abstract]   [Full Text] [Related]  

  • 14. Rocuronium antagonized by sugammadex for series of electroconvulsive therapy (ECT) in a patient with pseudocholinesterase deficiency.
    Batistaki C; Kesidis K; Apostolaki S; Kostopanagiotou G
    J ECT; 2011 Mar; 27(1):e47-8. PubMed ID: 21206368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experience on the use of sugammadex in a French university hospital].
    Beny K; Mirabaud AF; Piriou V; Aulagner G; Armoiry X
    Ann Fr Anesth Reanim; 2012 Jun; 31(6):568-9. PubMed ID: 22543096
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuromuscular blocking agents for electroconvulsive therapy: a systematic review.
    Mirzakhani H; Welch CA; Eikermann M; Nozari A
    Acta Anaesthesiol Scand; 2012 Jan; 56(1):3-16. PubMed ID: 22092267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rocuronium and sugammadex used effectively for electroconvulsive therapy in a patient with Brugada syndrome.
    Konishi J; Suzuki T; Kondo Y; Baba M; Ogawa S
    J ECT; 2012 Jun; 28(2):e21-2. PubMed ID: 22622300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The increases in potassium concentrations are greater with succinylcholine than with rocuronium-sugammadex in outpatient surgery: a randomized, multicentre trial.
    Sabo D; Jahr J; Pavlin J; Philip B; Shimode N; Rowe E; Woo T; Soto R
    Can J Anaesth; 2014 May; 61(5):423-32. PubMed ID: 24710957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rocuronium-sugammadex decreases the severity of post-electroconvulsive therapy agitation.
    Postaci A; Tiryaki C; Sacan O; Ornek D; Kalyoncu M; Dikmen B
    J ECT; 2013 Mar; 29(1):e2-3. PubMed ID: 23422529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of electroconvulsive therapy in neuroleptic malignant syndrome (NMS).
    Adityanjee
    Acta Psychiatr Scand; 1987 Nov; 76(5):603-4. PubMed ID: 3434334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.